@bhaskar108, many info talked in this streetsweeper are fake and false. 600K shares were scheduled/planned sale, really not a big deal. This company has never marketed in Europe for 6 years, they bought the technology from this Italy company (one person company) only about 2 years ago, they just assembled the sales team last year. Ignore the shorts and noises, long-term this stock shall at least gain 300%.
bhaskar108
⋅
@TimZhang, Thanks Tim, feeling better now. I thought this will rally after getting FDA approval, never expected this will drop . I were planning to hold till Nov 9th ER and will accept failure and move, now I am thinking to hold long-term. How much time do you expect for long term approx. 3 months / 1 year / 3 years ?
"TheStreetSweeper - TransEnterix TRXC When The CEO Sells, We Sell" - thestreetsweeper.org/undersurveillance/TransEnterix__TRXC___When_The_CEO_Sells__We_Sell
benzinga.com/general/biotech/17/10/10235978/short-seller-slams-transenterix-shares-slip
stocknewsgazette.com/2017/10/26/transenterix-inc-trxc-and-dextera-surgical-inc-dxtr-go-head-to-head/